Accessibility Menu
Liminatus Pharma Stock Quote

Liminatus Pharma (NASDAQ: LIMN)

$2.05
(43.4%)
+0.62
Price as of February 5, 2026, 3:40 p.m. ET

KEY DATA POINTS

Current Price
$1.98
Daily Change
(43.4%) +$0.62
Day's Range
$1.54 - $2.50
Previous Close
$1.43
Open
$1.71
Beta
1.48
Volume
71,172,378
Average Volume
3,291,629
Market Cap
$39M
Market Cap / Employee
$1.43M
52wk Range
$0.54 - $33.66
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
-$0.19
CAPs Rating
N/A
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Liminatus Pharma Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LIMNN/AN/AN/A-86%
S&P+13.99%+77.08%+12.11%+64%

Liminatus Pharma Company Info

Iris Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 5, 2020 and is headquartered in George Town, KY.

News & Analysis

No results found

No news articles found for Liminatus Pharma.

Financial Health

General

Q3 2025YOY Change
Revenue$0.00K0.0%
Gross Profit-$0.54K0.0%
Market Cap$45.20M0.0%
Market Cap / Employee$15.07M0.0%
Employees30.0%
Net Income-$1,823.35K-183.6%
EBITDA-$700.63K31.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$724.50K102.3%
Accounts Receivable$0.00K0.0%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$0.00K0.0%
Short Term Debt$1.44M-68.5%

Ratios

Q3 2025YOY Change
Return On Assets-116.93%-50.8%
Return On Invested Capital163.58%0.0%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$613.72K15.9%
Operating Free Cash Flow-$600.61K17.7%

Valuation

MetricQ2 2025Q3 2025YoY Change
Price to Book-278750.00-41750.00-
Price to Tangible Book Value-276250.63-41375.65-
Enterprise Value to EBITDA-160.09-900506.53-232.59-65.40-18.97%
Total Debt$5.12M$0.00K$1.44M$1.44M-68.45%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.